science1 publisher
Blocking the antioxidant enzyme PRX3 controlled disease in 67% of an early mesothelioma trial
Years of cancer trials that boosted antioxidants failed, so a University of Vermont team tried stripping mesothelioma cells of one antioxidant enzyme instead, and an early-phase trial reports disease control in two-thirds of patients.
Publishers:sciencedaily.com
Reality
- Evidence45
- Adoption15
- Hype gap+35
- Incentives78
- Confidence50